Nyxoah (NYXH) EBITDA Margin (2021 - 2026)
Nyxoah (NYXH) recorded quarterly EBITDA Margin of 57.47% in Q1 2026, up 100.01% quarter-over-quarter from 415380.45% in Q4 2025, and down 638.0% on a YoY basis from 10.68% in Q1 2025.
Nyxoah (NYXH) EBITDA Margin (2021 - 2026) Analysis & Trends
Nyxoah's EBITDA Margin history runs 6 years deep, the most recent figure standing at 57.47% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 638.0% year-over-year to 57.47%; the TTM figure through Mar 2026 stood at 152521.89% (down 16199206.0% YoY), while the FY2025 annual figure was 834.85%, down 1810152.0% from the prior year.
- EBITDA Margin was 57.47% for Q1 2026 at Nyxoah, up from 415380.45% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 2654875343.76% in Q1 2023 to a low of 2138157.89% in Q4 2023.
- Historically, EBITDA Margin has averaged 156085013.65% across 5 years, with a median of 1217.52% in 2023.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin jumped 2000000000 bps in 2023, then tumbled 2000000000 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 0.92% in 2022, then tumbled by 232881131 bps to 2138157.89% in 2023, then surged by 102 bps to 44766.51% in 2024, then slumped by 1028 bps to 415380.45% in 2025, then surged by 100 bps to 57.47% in 2026.
- The last three EBITDA Margin figures came in at 57.47% (Q1 2026), 415380.45% (Q4 2025), and 1226.88% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 1.63% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -9.90% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | 57.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.47% |
| Dec 31, 2025 | -415,380.45% |
| Sep 30, 2025 | -1,226.88% |
| Jun 30, 2025 | 1,610.52% |
| Mar 31, 2025 | 63.85% |
| Dec 31, 2024 | 44,766.51% |
| Sep 30, 2024 | -12,106.79% |
| Jun 30, 2024 | 1,860.57% |
| Mar 31, 2024 | 1,078,768.71% |
| Dec 31, 2023 | -2,138,157.89% |
| Sep 30, 2023 | 1,256.76% |
| Jun 30, 2023 | 1,217.52% |
| Mar 31, 2023 | 2,654,875,343.76% |
| Dec 31, 2022 | 0.92% |
| Sep 30, 2022 | 5,001.65% |
| Jun 30, 2022 | 919.66% |
| Mar 31, 2022 | 1,236.21% |
| Dec 31, 2021 | 28,813,559.32% |
| Sep 30, 2021 | 4,006.90% |
| Jun 30, 2021 | -3,649.41% |